Literature DB >> 18411264

Phosphorylation and stabilization of TAp63gamma by IkappaB kinase-beta.

Mary MacPartlin1, Shelya X Zeng, Hua Lu.   

Abstract

Post-translational modification of the p53 family members is key to their regulation. Here we report the phosphorylation of TAp63gamma, but not DeltaNp63gamma, by IkappaB kinase beta (IKKbeta). Activation of IKKbeta by gamma radiation or tumor necrosis factor-alpha led to increased TAp63gamma protein levels in cells. IKKbeta, but not its kinase-defective mutant IKKbeta-K44A, led to this observed stabilization of TAp63gamma. This stabilization of TAp63gamma in response to gamma radiation was significantly decreased in the absence of IKKbeta. Phosphorylation of TAp63gamma blocks ubiquitylation and possible degradation of this protein. We postulate that phosphorylation of TAp63gamma by IKKbeta stabilizes the TAp63gamma protein by blocking ubiquitylation-dependent degradation of this protein.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18411264      PMCID: PMC2414271          DOI: 10.1074/jbc.M801394200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  68 in total

1.  Split-hand/split-foot malformation is caused by mutations in the p63 gene on 3q27.

Authors:  P Ianakiev; M W Kilpatrick; I Toudjarska; D Basel; P Beighton; P Tsipouras
Journal:  Am J Hum Genet       Date:  2000-06-05       Impact factor: 11.025

2.  The biological response of MCF7 breast cancer cells to proteosome inhibition or gamma-radiation is unrelated to the level of p53 induction.

Authors:  L H Fallis; E Richards; D J O'Connor; S Zhong; J K Hsieh; G Packham; X Lu
Journal:  Apoptosis       Date:  1999-04       Impact factor: 4.677

3.  IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK.

Authors:  J D Woronicz; X Gao; Z Cao; M Rothe; D V Goeddel
Journal:  Science       Date:  1997-10-31       Impact factor: 47.728

4.  IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation.

Authors:  F Mercurio; H Zhu; B W Murray; A Shevchenko; B L Bennett; J Li; D B Young; M Barbosa; M Mann; A Manning; A Rao
Journal:  Science       Date:  1997-10-31       Impact factor: 47.728

5.  Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.

Authors:  Z Chen; J Hagler; V J Palombella; F Melandri; D Scherer; D Ballard; T Maniatis
Journal:  Genes Dev       Date:  1995-07-01       Impact factor: 11.361

6.  SSRP1 functions as a co-activator of the transcriptional activator p63.

Authors:  Shelya X Zeng; Mu-Shui Dai; David M Keller; Hua Lu
Journal:  EMBO J       Date:  2002-10-15       Impact factor: 11.598

Review 7.  The roles of p63 in cancer.

Authors:  Elsa R Flores
Journal:  Cell Cycle       Date:  2007-02-03       Impact factor: 4.534

8.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

Authors:  S J Kuerbitz; B S Plunkett; W V Walsh; M B Kastan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

9.  Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis.

Authors:  R Agami; G Blandino; M Oren; Y Shaul
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

10.  The E3 ubiquitin ligase Itch controls the protein stability of p63.

Authors:  Mario Rossi; Rami I Aqeilan; Michael Neale; Eleonora Candi; Paolo Salomoni; Richard A Knight; Carlo M Croce; Gerry Melino
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-14       Impact factor: 11.205

View more
  13 in total

1.  Radioprotective efficacy of dieckol against gamma radiation-induced cellular damage in hepatocyte cells.

Authors:  Velayutham Sadeeshkumar; Arul Duraikannu; Thiyagarajan Aishwarya; Prithi Jayaram; Samuthrapandian Ravichandran; Raghunathan Ganeshamurthy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-04-26       Impact factor: 3.000

2.  Iron Regulatory Protein 2 Exerts its Oncogenic Activities by Suppressing TAp63 Expression.

Authors:  Yanhong Zhang; Xiuli Feng; Jin Zhang; Xinbin Chen
Journal:  Mol Cancer Res       Date:  2020-04-10       Impact factor: 5.852

3.  Distinct interactors define the p63 transcriptional signature in epithelial development or cancer.

Authors:  Rosalba Pecorari; Francesca Bernassola; Gerry Melino; Eleonora Candi
Journal:  Biochem J       Date:  2022-06-30       Impact factor: 3.766

4.  IκB kinase β (IKKβ) inhibits p63 isoform γ (TAp63γ) transcriptional activity.

Authors:  Jun-Ming Liao; Yu Zhang; Wenjuan Liao; Sheyla X Zeng; Xiaohua Su; Elsa R Flores; Hua Lu
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

5.  TAp63 is a transcriptional target of NF-kappaB.

Authors:  Junfeng Wu; Johann Bergholz; Jinin Lu; Gail E Sonenshein; Zhi-Xiong Jim Xiao
Journal:  J Cell Biochem       Date:  2010-03-01       Impact factor: 4.429

6.  Cables1 protects p63 from proteasomal degradation to ensure deletion of cells after genotoxic stress.

Authors:  Ning Wang; Lankai Guo; Bo R Rueda; Jonathan L Tilly
Journal:  EMBO Rep       Date:  2010-06-18       Impact factor: 8.807

Review 7.  p63-related signaling at a glance.

Authors:  Matthew L Fisher; Seamus Balinth; Alea A Mills
Journal:  J Cell Sci       Date:  2020-09-11       Impact factor: 5.285

Review 8.  p63 steps into the limelight: crucial roles in the suppression of tumorigenesis and metastasis.

Authors:  Xiaohua Su; Deepavali Chakravarti; Elsa R Flores
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

9.  TAp63 induces senescence and suppresses tumorigenesis in vivo.

Authors:  Xuecui Guo; William M Keyes; Cristian Papazoglu; Johannes Zuber; Wangzhi Li; Scott W Lowe; Hannes Vogel; Alea A Mills
Journal:  Nat Cell Biol       Date:  2009-11-08       Impact factor: 28.824

Review 10.  p63 the guardian of human reproduction.

Authors:  Ivano Amelio; Francesca Grespi; Margherita Annicchiarico-Petruzzelli; Gerry Melino
Journal:  Cell Cycle       Date:  2012-11-19       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.